Search

Search Constraints

You searched for: Author/Creator Antonia, Scott

Search Results

1. 280 Both tumor intrinsic and extrinsic factors contribute to TIL resistance in lung cancer patients. (10th December 2020)

2. 280 Both tumor intrinsic and extrinsic factors contribute to TIL resistance in lung cancer patients. (9th November 2020)

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016)

4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016)

5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016)

6. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016)

7. 7/#178 Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFN beta induces an anti-tumor immune response in a high grade serous ovarian cancer mouse model. (4th December 2022)

8. 93 Targeting sirt2 rescues the metabolic fitness and effector functions of tumor-reactive T cells within the metabolically restricted tumor microenvironment. (9th November 2020)

9. Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM). (4th November 2015)

10. Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM). Issue 2 (December 2015)